Skip to main content

Table 4 Multivariate analyses of prognostic factors for CSS of stage III gastric cancer

From: Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer

VariablesAnalysis with CARAnalysis with PLR
HR (95% CI)p valueHR (95% CI)p value
Location
 Upper/Middle/Lower1 1 
 Whole1.099 (0865–1.395)0.4391.083 (0.852–1.376)0.516
Operative procedure
 Distal gastrectomy1 1 
 Total gastrectomy1.723 (1.110–2.676)0.0151.705 (1.100–2.643)0.017
TNM sub-stage
 IIIA10.00210.001
 IIIB2.019 (1.187–3.435)0.0102.015 (1.184–3.432)0.010
 IIIC2.617 (1.534–4.467)< 0.0012.799 (1.635–4.792)< 0.001
Tumor size (mm)
  ≤ 601 1 
  > 600.978 (0.630–1.519)0.9210.946 (0.605–1.481)0.809
CAR
 Low (≤0.47)1   
 High (> 0.47)2.771 (1.398–5.493)0.004  
PLR
 Low (≤172)  1 
 High (> 172)  1.552 (1.029–2.341)0.036
  1. TNM tumor-node-metastasis, CAR C-reactive protein/Albumin ratio, PLR platelet to lymphocyte ratio